Physician profile
Ata Atogho
NPI 1295982114
$2,214.21
in general payments reported to CMS, 2019-2025
13 companies · $16.86 in 2025
The $16.86 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,790 · 2020: $76.27 · 2021: $146 · 2022: $47.18 · 2024: $137 · 2025: $16.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,493.24 | 2019 | |
| Abbvie INC. | $335.85 | 2019-2021 | |
| Coopersurgical, INC. | $75.70 | 2019-2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $63.66 | 2024 | Thinprep 2000 Processor, Aptima |
| Mission Pharmacal Company | $40.87 | 2019-2021 | |
| Evofem Biosciences, INC. | $37.86 | 2024 | |
| Exeltis, USA INC. | $37.07 | 2022-2024 | Slynd |
| Lupin INC. | $30.46 | 2019-2021 | |
| Ethicon US, LLC | $27.76 | 2021 | |
| Covidien LP | $24.00 | 2019 | |
| Therapeuticsmd, INC. | $19.38 | 2021 | |
| Baxter Healthcare | $16.86 | 2025 | Perclot |
| Convatec INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ata Atogho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.